Breaking News

Ascentage Selects PharmaBlock as Preferred Provider

PharmaBlock will support Ascentage in accelerating its drug development pipeline with R&D, manufacturing capacity, and technological solutions.

By: Contract Pharma

Contract Pharma Staff

PharmaBlock Sciences, Inc., a chemistry product and service provider for pharmaceutical R&D processes, has signed a strategic partnership agreement with Ascentage Pharma, a clinical-stage biotechnology company developing therapies for cancer, chronic hepatitis B (CHB), and age-related diseases to advance drug development and manufacturing. PharmaBlock has served as long-term CDMO partner to Ascentage to advance development projects from discovery to preclinical and clinical manufactu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters